Company
Orchestra BioMed Holdings, Inc. $OBIO
Federal figures from USAspending, gathered Oct 25, 2026.
SEC revenue and federal obligations
- FY2026Oct 2025 to Sep 2026$0$33.5M year to Dec 31, 2025
- FY2025Oct 2024 to Sep 2025$0$2.6M year to Dec 31, 2024
- FY2024Oct 2023 to Sep 2024$0$2.8M year to Dec 31, 2023
- FY2023Oct 2022 to Sep 2023$0Revenue for this year not on file
- FY2022Oct 2021 to Sep 2022$0Revenue for this year not on file
What these numbers are
Obligated means an agency committed the money to this company in that period (a signed contract action), as reported to USAspending. It is not a payment and not revenue: a contract can be funded for several years at once, and revenue is booked as the work is done. Some years can exceed revenue for that reason.
Prime contracts only, and only what is published. Work the company does as a subcontractor is not in these figures, and classified contracts are not published on USAspending at all. A low share can mean either. Contract values, ceilings and options are never added in.
Which units count: the USAspending recipient that is the company's SEC registrant; units of the company that USAspending's own records place under it (as parent, or in its family tree); and subsidiaries from the company's SEC Exhibit 21 that carry its name. Joint ventures, units now owned by someone else, and records that only share a name are held back. Both lists are below.
Earlier years count the units the company owns today. A unit we checked by hand (its USAspending parent is out of date) counts from the date the company bought it, or, where no filing gives that date, from the first date a filing shows the company owning it. Other units count for every year shown until their purchase dates are loaded.
Revenue bars are the company's own fiscal year from its 10-K, placed in the federal year it ends in; its fiscal year can end in a different month than the government's.
Fiscal year 2022 onward. Federal fiscal years run October to September; the company's own fiscal year may differ.
Units counted (0), held back (8)
Held back: a matching name we could not tie to this company firmly enough. A miss is better than a wrong link.
- MOTUS GI, LLC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- MOTUS GI INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- ACCELERATED TECHNOLOGIES INC. (an old record with no UEI whose name is not exactly the company's SEC name)
- MOTUS GI HOLDINGS INC (an old record with no UEI whose name is not exactly the company's SEC name)
- ORCHESTRA BIOMED, INC. (an old record with no UEI whose name is not exactly the company's SEC name)
- ACCELERATED TECHNOLOGIES (an old record with no UEI whose name is not exactly the company's SEC name)
- MOTUS GI HOLDINGS, INC. (an old record with no UEI whose name is not exactly the company's SEC name)
- ACCELERATED TECHNOLOGIES, LLC (an old record with no UEI whose name is not exactly the company's SEC name)
Lobbying
No lobbying filings tied to this company in the Senate LDA records we hold.
PAC giving
No corporate PAC tied to this company in the FEC records we hold.
Contracts ending in the next 18 months
None in the contracts we hold for this company.
Amount: obligated to date. From the contracts in HillSignal's records tied to this ticker; the full list of contracts ending across government is on Recompetes.
Insider trades
- Sherman Darren See RemarksSold $95K · Oct 1, 2026
- Hochman David P See RemarksBought $48K · Sep 3, 2026
Open-market buys and sells from SEC Form 4 filings; grants and option exercises left out, and trades whose filed price failed our market check. A 10b5-1 plan is a trading schedule set in advance, so those sells say little about the insider's view. The plan box is on filings from April 2023 on.